Formycon AG
XETRA:FYB

Watchlist Manager
Formycon AG Logo
Formycon AG
XETRA:FYB
Watchlist
Price: 22.9 EUR -2.35% Market Closed
Market Cap: €404.6m

Profitability Summary

Formycon AG's profitability score is 24/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

24/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

24/100
Profitability
Score
24/100
Profitability
Score

Margins

Earnings Waterfall
Formycon AG

Margins Comparison
Formycon AG Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
DE
Formycon AG
XETRA:FYB
407.2m EUR
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
387B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.5B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
174.7B USD
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.5B USD
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.2B USD
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
86.9B AUD
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
44B EUR
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Formycon AG Competitors

Country Company Market Cap ROE ROA ROCE ROIC
DE
Formycon AG
XETRA:FYB
407.2m EUR
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
387B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.5B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
174.7B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.5B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.2B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
86.9B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
44B EUR
Loading...
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Formycon AG

Last Value
3-Years Average
FCF Margin
Conversion Rate